Seven months after the launch, Youli Meiya won the angel round of investment

In July 2021, "Youli Meiya" (hereinafter referred to as "Youli"), a dark horse of oral medicine advocating "oral aesthetics", has completed an angel round of financing. It is reported that this round of investment is led by a famous science and technology consumption medical angel investment institution. As a rookie of China's oral chain brand, Youli oral medical group cut into the traditional oral market with the scene concept of "social smile upgrading formula", and broke out an amazing "money making" ability in just seven months. After laying out 11 outpatient clinics in China and preparing for the construction of upstream factories, its momentum attracted the attention of capital, There is no lack of active contact with many well-known old players of the oral medicine track. With the change of the main consumer groups and the advent of the new consumption era, it has brought a huge shock to the traditional oral medicine industry. The social and beauty attributes of oral aesthetics are rapidly becoming the needs of the post-90s and post-95s. According to the 2020 white paper on Oral Medicine released by VBR, oral beauty, such as whitening, correction and smile aesthetics, has exceeded diseases and become the main diagnosis and treatment demand of oral consumers in China. Among them, female consumers account for 61.8%, and the age group aged 20-30 accounts for 56.9%. Under the condition that the aesthetic demand is gradually higher than the functional demand, the portrait of the target population of the oral diagnosis and treatment track is close to the medical beauty. Across health and aesthetics, it is considered to be a rare "intersection" between medicine and consumption.